CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Operating Activities
Net income	$ 355.0	$ 434.0
Adjustments to reconcile net income to net cash flows provided by (used in) operating activities:
Depreciation, amortization and accretion	49.0	61.0
Provision for credit losses	57.0	58.5
Deferred tax expense (benefit)	17.0	3.0
Loans originated for sale	(1,109.0)	(839.0)
Loans sold	1,069.0	821.0
Net (gain) loss on sale of loans	(10.0)	(1.0)
Net change in:
Interest receivable	(6.0)	(32.0)
Interest payable	3.0	29.0
Bank owned life insurance, excluding purchases	3.0	(7.0)
Other, net	(112.0)	(84.0)
Net cash flows provided by operating activities	316.0	443.0
Investing Activities
Net change in loans and leases, excluding sales and transfers	(1,857.0)	(1,917.0)
Debt securities available for sale:
Purchases	(864.0)	(262.0)
Maturities/payments	707.0	359.0
Debt securities held to maturity:
Purchases	(187.0)	(104.0)
Maturities/payments	283.0	271.0
Increase in premises and equipment	(91.0)	(71.0)
Net proceeds from sales of portfolio loans	776.0	0.0
Net cash flows provided by (used in) investing activities	(1,233.0)	(1,724.0)
Financing Activities
Demand (non-interest-bearing and interest-bearing) and savings accounts	605.0	(2,335.0)
Time deposits	1,453.0	2,178.0
Short-term borrowings	(944.0)	694.0
Proceeds from issuance of long-term borrowings	877.0	1,226.0
Repayment of long-term borrowings	(335.0)	(351.0)
Redemption of preferred stock	(111.0)	0.0
Repurchases of common stock	(3.0)	(37.0)
Cash dividends paid:
Preferred stock	(2.0)	(6.0)
Common stock	(131.0)	(130.0)
Other, net	10.0	5.0
Net cash flows provided by (used in) financing activities	1,419.0	1,244.0
Net Increase (Decrease) in Cash and Cash Equivalents	502.0	(37.0)
Cash and cash equivalents at beginning of period	1,576.0	1,674.0
Cash and Cash Equivalents at End of Period	$ 2,078.0	$ 1,637.0